Core Insights - AS Tallink Grupp reported a 4.9% increase in passenger transport in June 2025 compared to June 2024, with 598,977 passengers transported [1][2] - The company experienced a significant decrease in cargo units transported, down 11.2% in June and 22.8% in the second quarter compared to the previous year [2] - Passenger vehicles transported saw a slight increase of 1.0% in June and 1.4% in the second quarter compared to the same periods last year [2] Passenger Transport Summary - June 2025: 598,977 passengers, up from 570,803 in June 2024 (4.9% increase) [2] - Q2 2025: 1,488,128 passengers, up from 1,451,768 in Q2 2024 (2.5% increase) [2] - Key routes: - Finland - Sweden: 153,422 passengers in June 2025, down 0.6% from June 2024 [2] - Estonia - Finland: 386,211 passengers in June 2025, up 14.8% from June 2024 [2] - Estonia - Sweden: 59,344 passengers in June 2025, down 25.8% from June 2024 [2] Cargo Transport Summary - June 2025: 22,544 cargo units, down from 25,383 in June 2024 (11.2% decrease) [2] - Q2 2025: 67,038 cargo units, down from 86,813 in Q2 2024 (22.8% decrease) [2] - Key routes: - Finland - Sweden: 2,899 cargo units in June 2025, down 16.7% from June 2024 [2] - Estonia - Finland: 16,247 cargo units in June 2025, down 11.0% from June 2024 [2] - Estonia - Sweden: 3,398 cargo units in June 2025, down 7.0% from June 2024 [2] Passenger Vehicle Transport Summary - June 2025: 87,530 passenger vehicles, up from 86,651 in June 2024 (1.0% increase) [2] - Q2 2025: 212,782 passenger vehicles, up from 209,760 in Q2 2024 (1.4% increase) [2] - Key routes: - Finland - Sweden: 9,558 passenger vehicles in June 2025, up 5.6% from June 2024 [2] - Estonia - Finland: 73,712 passenger vehicles in June 2025, up 0.6% from June 2024 [2] - Estonia - Sweden: 4,260 passenger vehicles in June 2025, down 1.6% from June 2024 [2]

Core Insights - Bang & Olufsen reported a 4% revenue growth in Q4 and a 1% decline in local currencies for the full year, totaling DKK 2.6 billion [1] - The gross margin reached a record-high of 55.8% in Q4 and 55.0% for the year, indicating strong profitability [1] - The company achieved an EBIT margin before special items of 1.0% for the full year, with free cash flow amounting to DKK 16 million [1] Financial Highlights - For FY 2024/25, revenue declined by 1.4% year-on-year to DKK 2,553 million, with a 9% growth in branded channels [6] - Gross margin increased by 1.7 percentage points to 55.0%, while EBITDA before special items was DKK 271 million [6] - In Q4, revenue increased by 3.7% year-on-year to DKK 680 million, with a gross margin of 55.8% [6] Business Developments - The company launched several new products, including Beoplay H100 and Beoplay Eleven, and introduced the Bang & Olufsen Atelier for custom-made products [6] - The Win Cities initiative reported a sell-out growth of 30% year-on-year for the full year, with Q4 showing a 38% growth [6] - The monobrand network comprised 346 stores, reflecting a net reduction of 41 stores year-on-year [6] Outlook - The outlook for FY 2025/26 includes revenue growth in local currencies projected between 1% to 8% and an EBIT margin before special items expected to range from -3% to 1% [7] - Free cash flow is anticipated to be between -100 million to 0 million DKK [7]

Core Insights - The campaign "Where Art Meets China" launched by 798 Art District during Art Basel 2025 signifies a new phase in China's global artistic outreach, attracting attention from international visitors [1] - The campaign has previously made high-profile appearances in locations such as New York's Times Square and Beijing Capital International Airport, reaching tens of millions of potential audiences [2] - In 2025, 798 Art District hosted large-scale cultural events that collectively attracted over one million attendees, significantly benefiting local businesses and catalyzing billions in art trade [3] - 798 was recognized in Beijing's Top Ten Thematic Routes for inbound tourism, showcasing a blend of industrial heritage and international culture, and has attracted officials and journalists from over 50 countries [4] - Looking forward, 798 aims to enhance its role as a global platform for artistic collaboration and contribute to Beijing's vision as a world-class cultural capital [5]

Core Points - The Financial Supervisory Authority of Norway approved the prospectus for SalMar ASA's bond issues on 2 July 2025 [1] - The company is issuing two senior unsecured green bonds: NOK 3,250,000,000 maturing on 30 January 2030 and NOK 1,100,000,000 maturing on 30 January 2032 [1] Company Information - The prospectus and its appendices are available on SalMar ASA's official website [2] - For further inquiries, the Head of Investor Relations can be contacted via email or phone [2]

Core Insights - Novartis announced top-line results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) for adults with giant cell arteritis (GCA) [1][2] - The study did not show a statistically significant improvement in sustained remission at Week 52 compared to placebo [2][8] - Cosentyx demonstrated numerically better outcomes for cumulative steroid dose and steroid-related toxicity, with safety consistent with its known profile [2][8] Study Details - The GCAptAIN trial was a global Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted in 27 countries [4] - Patients were randomized into three treatment arms: Cosentyx 300 mg, Cosentyx 150 mg, or placebo, all with a glucocorticoid taper regimen [4] - The primary endpoint was to assess whether secukinumab 300 mg plus a 26-week glucocorticoid taper was superior to placebo plus a 52-week taper in achieving sustained remission at Week 52 [4] Product Information - Cosentyx is a fully human biologic that inhibits interleukin-17A, involved in inflammation for various immune-mediated diseases [5] - It is approved for multiple conditions including psoriatic arthritis, plaque psoriasis, ankylosing spondylitis, and hidradenitis suppurativa, with over 1.8 million patients treated globally since its launch in 2015 [5] - The product is supported by 10 years of real-world data demonstrating long-term safety and sustained efficacy [5] Disease Context - Giant cell arteritis (GCA) is the most common form of systemic vasculitis, primarily affecting individuals over 50 years of age [6] - GCA can lead to severe complications such as irreversible vision loss and life-threatening aortic aneurysms, necessitating prompt treatment [6]

STOCKHOLM, SWEDEN – July 3, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces an update from Organon on the development of the drug candidate OG-6219, acquired by Organon through its acquisition of Forendo Pharma in 2021. Following results from a Phase 2 clinical study with OG-6219, Organon plans to discontinue the clinical development of the drug candidate. Organon has announced results from the Phase 2 ELENA proof-of-concept, where the drug candidate OG-6219 was evaluated in patient ...

Core Insights - Pluxee demonstrated solid organic growth performance in Q3 Fiscal 2025, achieving total revenues of 310 million euros, which represents an 11.1% organic growth year-on-year [2][6][9] - The company confirmed its full-year financial objectives, reflecting strong execution and performance over the first nine months of the fiscal year [5][24] Financial Performance - Total revenues for Q3 Fiscal 2025 reached 310 million euros, up from 297 million euros in Q3 Fiscal 2024, marking an 11.1% organic growth and a 4.3% reported growth [2][9] - Operating revenue was 270 million euros, reflecting an 11.1% organic growth and a 5.4% reported growth [10][12] - Float revenue amounted to 39 million euros, growing 10.8% organically but declining 2.2% in reported terms [11][12] Regional Performance - Continental Europe generated 134 million euros in revenues, up 6.5% organically, while Latin America saw revenues of 121 million euros, growing 13.8% organically [2][15] - The Rest of the World reported revenues of 55 million euros, with a 15.2% organic growth despite a decline in reported terms [2][18] Business Segments - Employee Benefits segment generated 270 million euros in operating revenue, up 12.3% organically, driven by strong client acquisition and improved retention rates [7][12] - Other Products & Services reported 40 million euros in operating revenue, showing a modest 0.5% organic growth [14][36] M&A Activity - The company signed the acquisition of MyBenefits in Romania, which is expected to enhance technological capabilities and generate sustainable growth synergies [20][21][22] - Integration efforts for Cobee in Spain and Benefício Fácil in Brazil are ongoing, alongside a fully operational partnership with Santander [23][24] Outlook - Pluxee maintains its financial objectives for Fiscal 2025, expecting low double-digit organic growth in total revenues and float revenue [24][27] - The company anticipates a recurring EBITDA margin expansion of +150 basis points at Fiscal 2024 constant rates for Fiscal 2025 [27]

Core Viewpoint - Christina Lake Cannabis Corp. (CLC) announced a delay in filing its annual financial statements for the fiscal year ended February 28, 2025, due to extended audit processes and resource limitations [1][2]. Group 1: Filing Delay - CLC will not file its annual financial statements by the prescribed deadline of June 30, 2025, due to the audit taking longer than expected [1][2]. - The delay is attributed to the high level of testing required and limited staff availability, particularly concerning inventory and biological assets [2]. - The increased production levels and new product lines following the Midway acquisition have complicated the costing and inventory allocation processes [2]. Group 2: Auditor and Compliance - CLC is collaborating with its auditor DMCL LLP to ensure timely submission of the annual filings, with an expected filing date no later than July 14, 2025 [3]. - The company has applied for a management cease trade order (MCTO) to prevent the CEO and CFO from trading in CLC securities until the filings are completed [3]. - The MCTO application is subject to the risk of not being successful, which could lead to further trading restrictions [3][4]. Group 3: Company Operations - CLC is a licensed cannabis producer with a focus on high-quality extracts and distillates, operating on a 32-acre property with over 950,000 square feet of outdoor grow space [5]. - The company has secured necessary licenses from Health Canada for cultivation, processing, and research and development [5]. - CLC's production strategy includes proprietary strains developed for outdoor cultivation to enhance extraction quality [5].

Group 1: Industry Insights - Global demand for high-performance consumer electronics is increasing, with an 18% year-over-year rise in electronics sales during Prime Day 2024 [1] - Gaming monitors and productivity devices are among the top-performing categories in the electronics market [1] Group 2: Company Overview - KOORUI, founded on May 4, 2021, aims to enhance the human visual experience through high-quality display products [3] - The brand has quickly expanded across major online platforms, supporting various use cases from gaming to content creation [3] Group 3: Product Launch and Strategy - KOORUI has announced a new product lineup for Prime Day, including the G2741L with Dual-Mode display technology and the G2411P with a 200Hz refresh rate [2][6] - The company’s product strategy focuses on user context rather than specifications alone, differentiating it in a crowded display market [5] Group 4: Technical Foundation - KOORUI benefits from the industrial and supply chain expertise of one of China's leading display manufacturing enterprises, allowing it to balance innovation, quality, and scalability [4] - The brand is powered by HKC's semiconductor display expertise, blending innovative panel manufacturing with human-centered design [8] Group 5: Market Positioning - Prime Day serves as a global stage for KOORUI to enhance brand visibility and showcase the strength of Chinese display technology internationally [7]

Core Insights - DMG Blockchain Solutions Inc. reported a decrease in its realized hashrate to 1.56 EH/s in June 2025, down 18% from 1.89 EH/s in May 2025, due to an unscheduled electrical outage and challenges with its hydro infrastructure [1][2][8] - The company is addressing issues with its hydro infrastructure, including contamination from manufacturer quality control problems, and aims to improve its hashrate closer to its potential of 0.4 EH/s [2][3] - DMG plans to source new hydro infrastructure from alternative manufacturers to enhance quality control and efficiency, with a goal to expand its capacity to 3 EH/s by the end of 2025 [3][6] Operational Performance - DMG's bitcoin balance at the end of June was 341 BTC, a decrease from 350 BTC in May, as the company sold bitcoin to fund operating expenses and reduce its loan balance with Sygnum Bank [4][8] - The company mined 23 BTC in June, down from 31 BTC in May 2025 [8] Strategic Developments - DMG has executed a binding agreement to develop a new data processing center in a Canadian province outside of British Columbia, which will utilize low-cost renewable energy and is expected to add approximately 1 EH/s of mining capacity by the second half of 2026 [5][6] - The CEO highlighted ongoing discussions with Canadian governmental agencies, particularly regarding military spending and AI, which may align with DMG's strategic objectives [6] Employee Incentives - DMG granted a total of 201,607 stock options and 1,275,000 restricted stock units (RSUs) to employees and directors, aimed at aligning long-term performance with the company's growth [7]